Biosyent Inc (TSXV:RX)
C$ 14.8 -0.20 (-1.33%) Market Cap: 167.71 Mil Enterprise Value: 162.06 Mil PE Ratio: 18.78 PB Ratio: 3.76 GF Score: 100/100

Biosyent Inc (TSXV:RX) Transcripts

  • 1